vTv Therapeutics Files 8-K for March 31, 2025
Ticker: VTVT · Form: 8-K · Filed: Mar 31, 2025 · CIK: 1641489
| Field | Detail |
|---|---|
| Company | Vtv Therapeutics Inc. (VTVT) |
| Form Type | 8-K |
| Filed Date | Mar 31, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
vTv Therapeutics filed a standard 8-K on 3/31/25, no major news.
AI Summary
vTv Therapeutics Inc. filed an 8-K on March 31, 2025, reporting on financial statements and exhibits. The filing does not appear to contain any material new information beyond standard reporting requirements for the period ending March 31, 2025. The company is incorporated in Delaware and headquartered in High Point, NC.
Why It Matters
This filing indicates routine corporate reporting and does not appear to disclose any significant new events or financial changes that would immediately impact the company's stock or operations.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for financial statements and exhibits, with no indication of significant new events or material changes.
Key Players & Entities
- vTv Therapeutics Inc. (company) — Registrant
- March 31, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- High Point, NC (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on financial statements and exhibits for the period ending March 31, 2025.
When was this 8-K filed?
This 8-K was filed as of March 31, 2025.
Where is vTv Therapeutics Inc. headquartered?
vTv Therapeutics Inc. is headquartered at 3980 Premier Drive, Suite 310, High Point, NC 27265.
In which state is vTv Therapeutics Inc. incorporated?
vTv Therapeutics Inc. is incorporated in Delaware.
Does this filing indicate any new material events or disclosures?
Based on the provided text, this filing appears to be a routine report of financial statements and exhibits, and does not explicitly mention any new material events or disclosures beyond standard reporting.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 31, 2025 regarding vTv Therapeutics Inc. (VTVT).